Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Joshua J Dennis"'
Autor:
Jonathon W Senefeld, Patrick W Johnson, Katie L Kunze, Evan M Bloch, Noud van Helmond, Michael A Golafshar, Stephen A Klassen, Allan M Klompas, Matthew A Sexton, Juan C Diaz Soto, Brenda J Grossman, Aaron A R Tobian, Ruchika Goel, Chad C Wiggins, Katelyn A Bruno, Camille M van Buskirk, James R Stubbs, Jeffrey L Winters, Arturo Casadevall, Nigel S Paneth, Beth H Shaz, Molly M Petersen, Bruce S Sachais, Matthew R Buras, Mikolaj A Wieczorek, Benjamin Russoniello, Larry J Dumont, Sarah E Baker, Ralph R Vassallo, John R A Shepherd, Pampee P Young, Nicole C Verdun, Peter Marks, N Rebecca Haley, Robert F Rea, Louis Katz, Vitaly Herasevich, Dan A Waxman, Emily R Whelan, Aviv Bergman, Andrew J Clayburn, Mary Kathryn Grabowski, Kathryn F Larson, Juan G Ripoll, Kylie J Andersen, Matthew N P Vogt, Joshua J Dennis, Riley J Regimbal, Philippe R Bauer, Janis E Blair, Zachary A Buchholtz, Michaela C Pletsch, Katherine Wright, Joel T Greenshields, Michael J Joyner, R Scott Wright, Rickey E Carter, DeLisa Fairweather
Publikováno v:
PLoS Medicine, Vol 18, Iss 12, p e1003872 (2021)
BackgroundThe United States (US) Expanded Access Program (EAP) to coronavirus disease 2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative age
Externí odkaz:
https://doaj.org/article/b6326af583c74bfba59628eb0bc601dc
Autor:
Jonathon W. Senefeld, PhD, Ellen K. Gorman, BS, Patrick W. Johnson, BS, M. Erin Moir, PhD, Stephen A. Klassen, PhD, Rickey E. Carter, PhD, Nigel S. Paneth, MD, David J. Sullivan, MD, Olaf H. Morkeberg, BA, R. Scott Wright, MD, DeLisa Fairweather, PhD, Katelyn A. Bruno, PhD, Shmuel Shoham, MD, Evan M. Bloch, MBChB, MS, Daniele Focosi, MD, Jeffrey P. Henderson, MD, PhD, Justin E. Juskewitch, MD, PhD, Liise-Anne Pirofski, MD, Brenda J. Grossman, MD, MPH, Aaron A.R. Tobian, MD, PhD, Massimo Franchini, MD, Ravindra Ganesh, MBBS, MD, Ryan T. Hurt, MD, PhD, Neil E. Kay, MD, Sameer A. Parikh, MBBS, Sarah E. Baker, PhD, Zachary A. Buchholtz, BS, Matthew R. Buras, BS, Andrew J. Clayburn, BS, Joshua J. Dennis, BS, Juan C. Diaz Soto, MD, Vitaly Herasevich, MD, PhD, Allan M. Klompas, MB, BCh, BAO, Katie L. Kunze, PhD, Kathryn F. Larson, MD, John R. Mills, PhD, Riley J. Regimbal, BS, Juan G. Ripoll, MD, Matthew A. Sexton, MD, John R.A. Shepherd, MD, James R. Stubbs, MD, Elitza S. Theel, PhD, Camille M. van Buskirk, MD, Noud van Helmond, MD, Matthew N.P. Vogt, MD, Emily R. Whelan, BS, Chad C. Wiggins, PhD, Jeffrey L. Winters, MD, Arturo Casadevall, MD, PhD, Michael J. Joyner, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 7, Iss 5, Pp 499-513 (2023)
Objective: To examine the association of COVID-19 convalescent plasma transfusion with mortality and the differences between subgroups in hospitalized patients with COVID-19. Patients and Methods: On October 26, 2022, a systematic search was performe
Externí odkaz:
https://doaj.org/article/dadeeaf646b74fc8991c25a417a35f18
Autor:
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, M. Erin Moir, Stephen A. Klassen, Rickey E. Carter, Nigel S. Paneth, David J. Sullivan, Olaf H. Morkeberg, R. Scott Wright, DeLisa Fairweather, Katelyn A. Bruno, Shmuel Shoham, Evan M. Bloch, Daniele Focosi, Jeffrey P. Henderson, Justin E. Juskewitch, Liise-anne Pirofski, Brenda J. Grossman, Aaron A.R. Tobian, Massimo Franchini, Ravindra Ganesh, Ryan T. Hurt, Neil E. Kay, Sameer A. Parikh, Sarah E. Baker, Zachary A. Buchholtz, Matthew R. Buras, Andrew J. Clayburn, Joshua J. Dennis, Juan C. Diaz Soto, Vitaly Herasevich, Allan M. Klompas, Katie L. Kunze, Kathryn F. Larson, John R. Mills, Riley J. Regimbal, Juan G. Ripoll, Matthew A. Sexton, John R.A. Shepherd, James R. Stubbs, Elitza S. Theel, Camille M. van Buskirk, Noud van Helmond, Matthew N.P. Vogt, Emily R. Whelan, Chad C. Wiggins, Jeffrey L. Winters, Arturo Casadevall, Michael J. Joyner
IMPORTANCEMany hospitalized patients with COVID-19 have been treated with convalescent plasma. However, it is uncertain whether this therapy lowers mortality and if so, if the mortality benefit is larger among specific subgroups, such as recipients o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ff3c217778226605049b69da35168ab
https://doi.org/10.1101/2023.01.11.23284347
https://doi.org/10.1101/2023.01.11.23284347
Autor:
Joshua J. Dennis, Bruce D. Johnson, Michael J. Joyner, Chad C. Wiggins, Troy J. Cross, Jennifer M J Isautier, Joshua R. Smith
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Scientific Reports
Scientific Reports
We describe here a novel protocol that sequentially combines venous followed by arterial occlusions to determine muscle blood flow and O2 uptake from a single measurement point using near-infrared spectroscopy (NIRS) during handgrip exercise. NIRS da
Autor:
R. Scott Wright, Jonathon W. Senefeld, Brian P. Butterfield, Joshua J. Dennis, Elizabeth R. Lesser, Juan C. Diaz Soto, Chad C. Wiggins, Katie L. Kunze, Robert F. Rea, Matthew A. Sexton, Patrick W. Johnson, Peter W. Marks, Emily R. Whelan, Jeffrey L. Winters, Kathryn F. Larson, Nicole C. Verdun, Andrew J. Clayburn, Riley J. Regimbal, Matthew R. Spiegel, Matthew N.P. Vogt, Janis E. Blair, Philippe R. Bauer, Sarah E. Baker, Allan M. Klompas, Nigel Paneth, David O. Hodge, Noud van Helmond, Vitaly Herasevich, Michael J. Joyner, De Lisa Fairweather, John R. A. Shepherd, James R. Stubbs, Matthew R. Buras, Rickey E. Carter, Camille M. van Buskirk, Kylie J. Andersen, Arturo Casadevall, Juan G. Ripoll, Katelyn A. Bruno, Stephen A. Klassen
Publikováno v:
Mayo Clinic Proceedings
OBJECTIVE: To provide an update on key safety metrics after transfusion of convalescent plasma in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated safety in 5000 hospitalized patients. PATIENTS AND METHODS: From April
Autor:
Matthew R. Buras, Michaela C. Pletsch, John Mills, Juan G. Ripoll, R. Scott Wright, Jeffrey L. Winters, Matthew A. Sexton, Kathryn F. Larson, Matthew N.P. Vogt, M. Petersen, Stephen A. Klassen, Robert F. Rea, Katie L. Kunze, James R. Stubbs, Kylie J. Andersen, Elitza S. Theel, Joshua J. Dennis, Michael A. Golafshar, Juan C. Diaz Soto, Katelyn A. Bruno, Nicole C. Verdun, DeLisa Fairweather, Riley J. Regimbal, Katherine A. Senese, Chad C. Wiggins, Elizabeth R. Lesser, Zachary A. Buchholtz, Philippe R. Bauer, Andrew J. Clayburn, Vitaly Herasevich, Michael J. Joyner, Emily R. Whelan, John R. A. Shepherd, Rickey E. Carter, Allan M. Klompas, Noud van Helmond, Janis E. Blair, Arturo Casadevall, Jonathon W. Senefeld, Patrick W. Johnson, Peter W. Marks, Camille M. van Buskirk, Sarah E. Baker, Nigel Paneth
Publikováno v:
Nature Communications, 12, 1
Nature Communications, 12
Nature Communications, Vol 12, Iss 1, Pp 1-6 (2021)
Nature Communications
Nature Communications, 12
Nature Communications, Vol 12, Iss 1, Pp 1-6 (2021)
Nature Communications
Successful therapeutics and vaccines for coronavirus disease 2019 (COVID-19) have harnessed the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Evidence that SARS-CoV-2 exists as locally evolving variants suggests tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f30af10990c7444313e9d945996a37b
Autor:
Arturo Casadevall, John Mills, Matthew A. Sexton, Elizabeth R. Lesser, Katelyn A. Bruno, Juan C. Diaz Soto, David O. Hodge, Chad C. Wiggins, R. Scott Wright, Nicole C. Verdun, Patrick W. Johnson, Emily R. Whelan, Peter W. Marks, Robert F. Rea, Camille M. van Buskirk, Jeffrey L. Winters, Sarah E. Baker, Kathryn F. Larson, Matthew N.P. Vogt, Nigel Paneth, Riley J. Regimbal, Michael J. Joyner, Matthew R. Buras, Janis E. Blair, John R. A. Shepherd, Vitaly Herasevich, Rickey E. Carter, Allan M. Klompas, James R. Stubbs, Noud van Helmond, De Lisa Fairweather, Andrew J. Clayburn, Kylie J. Andersen, Jonathon W. Senefeld, Philippe R. Bauer, Elitza S. Theel, Joshua J. Dennis, Stephen A. Klassen, Juan G. Ripoll, Katie L. Kunze
Publikováno v:
The New England Journal of Medicine, 384, 11, pp. 1015-1027
The New England Journal of Medicine
New England Journal of Medicine
The New England Journal of Medicine, 384, 1015-1027
The New England Journal of Medicine
New England Journal of Medicine
The New England Journal of Medicine, 384, 1015-1027
Contains fulltext : 232887.pdf (Publisher’s version ) (Open Access) BACKGROUND: Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19) under the presumption that such plasma contains potentially therapeutic antibodies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fad090a4e9d82ad0d49425346100bbb2
https://repository.ubn.ru.nl/handle/2066/232887
https://repository.ubn.ru.nl/handle/2066/232887
Autor:
James R. Stubbs, Patrick W. Johnson, Elizabeth R. Lesser, Sarah E. Baker, Nigel Paneth, Vitaly Herasevich, Matthew R. Buras, Katelyn A. Bruno, Kathryn F. Larson, John Mills, Matthew A. Sexton, Noud van Helmond, Matthew N.P. Vogt, Robert F. Rea, David O. Hodge, Jeffrey L. Winters, R. Scott Wright, Juan C. Diaz Soto, Camille M. van Buskirk, Stephen A. Klassen, Riley J. Regimbal, Chad C. Wiggins, Arturo Casadevall, Andrew J. Clayburn, Katie L. Kunze, Philippe R. Bauer, Juan G. Ripoll, Jonathon W. Senefeld, Allan M. Klompas, DeLisa Fairweather, Janis E. Blair, Emily R. Whelan, John R. A. Shepherd, Rickey E. Carter, Elitza S. Theel, Joshua J. Dennis, Kylie J. Andersen, Michael J. Joyner
Publikováno v:
medRxiv
ImportancePassive antibody transfer is a longstanding treatment strategy for infectious diseases that involve the respiratory system. In this context, human convalescent plasma has been used to treat coronavirus disease 2019 (COVID-19), but the effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eda8efd1b276c5e5674c071d29ebbc08
https://doi.org/10.1101/2020.08.12.20169359
https://doi.org/10.1101/2020.08.12.20169359
Autor:
DeLisa Fairweather, Matthew R. Buras, Arturo Casadevall, Nicole C. Verdun, Joshua J. Dennis, Allan M. Klompas, Philippe R. Bauer, Robert F. Rea, Stephen A. Klassen, Camille M. van Buskirk, Michael J. Joyner, Elizabeth R. Lesser, Jonathon W. Senefeld, Jeffrey L. Winters, Andrew J. Clayburn, Emily R. Whelan, Katie L. Kunze, Juan G. Ripoll, John R. A. Shepherd, Rickey E. Carter, Sarah E. Baker, Nigel Paneth, Vitaly Herasevich, Chad C. Wiggins, Katelyn A. Bruno, Patrick W. Johnson, Peter W. Marks, Kylie J. Andersen, R. Scott Wright, Kathryn F. Larson, Matthew N.P. Vogt, David O. Hodge, Matthew R. Spiegel, Janis E. Blair, James R. Stubbs, Riley J. Regimbal
Publikováno v:
medRxiv
BACKGROUNDConvalescent plasma is the only antibody-based therapy currently available for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence and sound biological plausibility. Although promising, convalescent plasma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a627b90210bdc9dfdddbaacc8a973d9a
https://doi.org/10.1101/2020.05.12.20099879
https://doi.org/10.1101/2020.05.12.20099879
Autor:
Troy J. Cross, Jennifer M J Isautier, Chad C. Wiggins, Bruce D. Johnson, Joshua J. Dennis, Joshua R. Smith, Micheal J. Joyner
Publikováno v:
The FASEB Journal. 34:1-1